Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;73(7):1459-1469.
doi: 10.1111/all.13411. Epub 2018 Jan 26.

Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes

Affiliations

Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes

B Liao et al. Allergy. 2018 Jul.

Abstract

Background: The expression of chronic rhinosinusitis (CRS) is multidimensional. Disease heterogeneity in patients with CRS remains poorly understood. This study aimed to identify endotypes of CRS using cluster analysis by integrating multidimensional characteristics and to explore their association with treatment outcomes.

Methods: A total of 28 clinical variables and 39 mucosal cellular and molecular variables were analyzed using principal component analysis. Cluster analysis was performed on 246 prospectively recruited Chinese CRS patients with at least 1-year postoperative follow-up. Difficult-to-treat CRS was characterized in each generated cluster.

Results: Seven subject clusters were identified. Cluster 1 (13.01%) was comparable to the classic well-defined eosinophilic CRS with polyps, having severe disease and the highest proportion of difficult-to-treat CRS. Patients in cluster 2 (16.26%) and cluster 4 (13.82%) had relatively lower proportions of presence of polyps and presented mild inflammation with moderate proportions of difficult-to-treat cases. Subjects in cluster 2 were highly atopic. Cluster 3 (7.31%) and cluster 6 (21.14%) were characterized by severe or moderate neutrophilic inflammation, respectively, and with elevated levels of IL-8 and high proportions of difficult-to-treat CRS. Cluster 5 (4.07%) was a unique group characterized by the highest levels of IL-10 and lacked difficult-to-treat cases. Cluster 7 (24.39%) demonstrated the lowest symptom severity, a low proportion of difficult-to-treat CRS, and low inflammation load. Finally, we found that difficult-to-treat CRS was associated with distinct clinical features and biomarkers in the different clusters.

Conclusions: Distinct clinicopathobiologic clusters of CRS display differences in clinical response to treatments and characteristics of difficult-to-treat CRS.

Keywords: chronic rhinosinusitis; cluster analysis; difficult-to-treatment; nasal polyps.

PubMed Disclaimer

Conflict of interest statement

Disclosure of conflict of interest: None

Figures

Fig 1
Fig 1
A modified heat map indicating the relative degree to which some key variables were present across clusters. The graded color scheme contains 5 shades of blue, representing the 20th (lightest), 40th, 60th, 80th, and 100th (darkest) percentiles of the data for each row. For continuous variables, results are expressed as medians. Categorical variables are summarized using percentage. The protein concentrations of detected molecular markers were normalized to total tissue protein levels. AR, allergic rhinitis; VAS, visual analog scale; CT, computed tomography; HPF, high-power field.
Fig 2
Fig 2
The proportions of difficult-to-treat chronic rhinosinusitis (CRS) differed by subject clusters. Fisher exact test was used to test the differences in proportions across 7 clusters. An overall P value indicates differences among the 7 clusters. An overall P value less than 0.05 indicates that at least one out of the 7 clusters was different from other clusters.

Similar articles

Cited by

References

    1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology supplement. 2012;23:1–299. - PubMed
    1. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004;114:155–212. - PMC - PubMed
    1. Cao PP, Li HB, Wang BF, Wang SB, You XJ, Cui YH, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009;124:478–84. - PubMed
    1. Akdis CA, Bachert C, Cingi C, Dykewicz MS, Hellings PW, Naclerio RM, et al. Endotypes and phenotypes of chronic rhinosinusitis A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131:1479–90. - PMC - PubMed
    1. Soler ZM, Hyer JM, Rudmik L, Ramakrishnan V, Smith TL, Schlosser RJ. Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis. J Allergy Clin Immunol. 2016;137:1054–62. - PMC - PubMed

Publication types

MeSH terms